Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM134A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
INSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF252P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PMS2P9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MCTP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WASF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RORA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALCAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXJ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PREB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOP14-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEFH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on